BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Teva
Cantor Fitzgerald
Fuji
US Department of Justice
Dow
Citi
Express Scripts
Argus Health
Deloitte

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090920

« Back to Dashboard

NDA 090920 describes ESTRADIOL VALERATE, which is a drug marketed by Luitpold, Sandoz Inc, Watson Labs, and Watson Labs Inc, and is included in five NDAs. It is available from one supplier. Additional details are available on the ESTRADIOL VALERATE profile page.

The generic ingredient in ESTRADIOL VALERATE is estradiol valerate. There are seventy-five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the estradiol valerate profile page.
Summary for 090920
Tradename:ESTRADIOL VALERATE
Applicant:Luitpold
Ingredient:estradiol valerate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 090920
Ingredient-typeEstradiol Congeners
Mechanism of ActionEstrogen Receptor Agonists
Suppliers and Packaging for NDA: 090920
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 090920 ANDA Perrigo Company 0574-0870 0574-0870-05 1 VIAL, MULTI-DOSE in 1 CARTON (0574-0870-05) > 5 mL in 1 VIAL, MULTI-DOSE
ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 090920 ANDA Perrigo Company 0574-0872 0574-0872-05 1 VIAL, MULTI-DOSE in 1 CARTON (0574-0872-05) > 5 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:Jan 19, 2010TE:AORLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40MG/ML
Approval Date:Jan 19, 2010TE:AORLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
US Army
Colorcon
Cantor Fitzgerald
Johnson and Johnson
UBS
Cerilliant
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot